Catalyze B.V.

Catalyze B.V. is an SME in Amsterdam-Duivendrecht, Netherlands that has taken part in 15 EU-funded projects since 2017, receiving €3.0M in EU funding.

EU funding received€3.0M
EU projects15
As coordinator0
Running now9
First EU project2017
Latest project2025
CountryNetherlands
EU registration (PIC)906667634
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Catalyze B.V.'s own share of each project, not the project's full budget.

  • Horizon Europe€2.2M · 11 projects
  • Horizon 2020€830k · 4 projects

Projects

15 EU-funded projects, newest first. Each links to the official record.

  • SMARTTESTAssociated partner

    European Doctoral Network for Resilient Remote Healthcare using Intelligent Sensing and Communication Technologies

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • EvaMobsPartner

    Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €209ktheir share
  • iCARE4CVDPartner

    INDIVIDUALISED CARE FROM EARLY RISK OF CARDIOVASCULAR DISEASE TO ESTABLISHED HEART FAILURE

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €542ktheir share
  • NO-CANCER-NETAssociated partner

    Advanced Engineering of Nitric Oxide Based Therapeutics for Triple Negative Breast Cancer Training Network

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • SILKinkPartner

    Revolutionary silk-based bioink for 3D printing of ex vivo bone marrow models to advance drug development and personalized medicine

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €173ktheir share
  • RESTORE VISIONPartner

    Novel advanced and repurposed therapeutics for vision restoration in a group of severe rare ocular surface diseases: from validation to first clinical investigations

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €250ktheir share
  • RETORNAAssociated partner

    Targeting RNA as an approach for treating retinal disease

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • BUCCAL-PEPPartner

    Development of a multifunctional biomaterial patch for buccal delivery of peptide-analogue treatments

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €343ktheir share
  • ELR-SCARPartner

    A novel multi-functional elastin-like recombinant hydrogel for the prevention of scar tissue formation following a myocardial infarction: ""ELR-SCAR""""

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €174ktheir share
  • SMARTSHAPEPartner

    Development of a smart shape-memory sensor for biological pressure monitoring applications

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €311ktheir share
  • iMPactPartner

    Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anti-cytokine activity

    Horizon Europe · 2021–2023 · Project on CORDIS ↗

    €159ktheir share
  • EHRA - PATHSPartner

    Addressing multimorbidity in elderly atrial fibrillation patients through interdisciplinary, tailored, patient-centered care pathways

    Horizon 2020 · 2021–2026 · Project on CORDIS ↗

    €317ktheir share
  • PROFIDPartner

    Implementation of personalised risk prediction and prevention of sudden cardiac death after myocardial infarction

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €17ktheir share
  • iPSpinePartner

    Induced pluripotent stem cell-based therapy for spinal regeneration

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €274ktheir share
  • ESCAPE-NETPartner

    European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €223ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • RNA
  • adverse drug reactions
  • biomaterials
  • biomolecules
  • cardiac arrhythmia
  • coronaviruses
  • databases
  • diabetes
  • drug discovery
  • graft versus host disease
  • medicinal chemistry
  • mortality
  • ophthalmology
  • pandemics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime